Boost for dopamine packaging protects brain in Parkinson's model

Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

Researchers from Emory's Rollins School of Public Health discovered that an increase in the protein that helps store dopamine, a critical brain chemical, led to enhanced dopamine neurotransmission and protection from a Parkinson's disease-related neurotoxin in mice.

Dopamine and related neurotransmitters are stored in small storage packages called vesicles by the vesicular monoamine transporter (VMAT2). When released from these packages can help regulate movement, pleasure, and emotional response. Low dopamine levels are associated with neurodegenerative diseases such as Parkinson's disease and recent research has shown that VMAT2 function is impaired in people with the disease.

Lead researcher Gary W. Miller, PhD, professor and associate dean for research at the Rollins School of Public Health and his team generated transgenic mice with increased levels of VMAT2 and found it led to an increase in . In addition, the group found improved outcomes on anxiety and depressive behaviors, increased movement, and protection from MPTP, the chemical that can cause Parkinson's disease-related damage in the brain.

The complete study is available in the June 17, 2014 edition of Proceedings of the National Academy of Sciences (PNAS).

According to Miller, "This work suggests that enhanced vesicular filling can be sustained over time and may be a viable therapeutic approach for a variety of central nervous system disorders that involve the storage and release of dopamine, serotonin, or norepinephrine."

More information: Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1401191111

add to favorites email to friend print save as pdf

Related Stories

Mouse model of Parkinson's reproduces nonmotor symptoms

Jun 23, 2009

The classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. Over the last decade, neurologists have been paying greater attention to non-motor symptoms, such as digestive and sleep problems, ...

Natural compound mitigates effects of methamphetamine abuse

Nov 19, 2013

Studies have shown that resveratrol, a natural compound found in colored vegetables, fruits and especially grapes, may minimize the impact of Parkinson's disease, stroke and Alzheimer's disease in those who maintain healthy ...

REM sleep disturbance signals future neurodegenerative disease

Jun 09, 2014

How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists ...

Recommended for you

Can exercise help people with Parkinson's disease?

Dec 31, 2014

Exercise may help people with Parkinson's disease improve their balance, ability to move around and quality of life, even if it does not reduce their risk of falling, according to a new study published in ...

Tackling Parkinson's with targeted therapeutic vaccines

Dec 24, 2014

Clinical trials are about to begin on a new Parkinson's disease vaccine that could offer patients significant improvements over current treatments. The vaccine, developed through the FP7-funded SYMPATH project, ...

Parkinson's disease reverted at a experimental stage

Dec 19, 2014

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide. The experiments ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.